Castle Biosciences Inc (CSTL) — Capital Reinvestment Ratio
Castle Biosciences Inc (CSTL) has a Capital Reinvestment Ratio of 0.66x as of September 2025, meaning it reinvests 1% of its operating cash flow ($22.63 Million) in capital expenditures ($14.83 Million). See CSTL net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Castle Biosciences Inc Capital Reinvestment Ratio (2019–2024)
This chart tracks Castle Biosciences Inc's Capital Reinvestment Ratio across 3 annual periods. Check how aggressively does Castle Biosciences Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Castle Biosciences Inc (2019–2024)
Year-by-year Capital Reinvestment Ratio for Castle Biosciences Inc from 2019 to 2024. For live market cap and broader valuation context, see CSTL company net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.44x | $64.87 Million | $28.33 Million | ▼ -9.3% |
| 2020 | 0.48x | $9.87 Million | $4.75 Million | ▲ +260.6% |
| 2019 | 0.13x | $7.01 Million | $937.00K | — |